SABBY MANAGEMENT, LLC 13D and 13G filings for Titan Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2020-09-24 09:44 am Purchase | 2020-09-24 | 13G | Titan Pharmaceuticals, Inc. TTNP | SABBY MANAGEMENT, LLC | 16,200 11.000% | 10,663 (+192.57%) | Filing |